NCT00000240已完成2 期
Combined Buprenorphine and Behavioral Treatment Without Contingent Reinforcement
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Drug use
研究概览
简要总结
The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 23 Years 至 47 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Drug use
Retention
Weeks abstinent
Weeks continuous abstinence
Overall treatment outcome
Opioid dependence and psychiatric status
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12Opioid-Related DisordersNCT00000230University of Vermont
已完成
2 期
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13Opioid-Related DisordersNCT00000231National Institute on Drug Abuse (NIDA)
已完成
2 期
Combined Pharmaco/Behavior Therapy in Adolescent SmokersNicotine DependenceNicotine Use DisorderNCT00330187Medical University of South Carolina134
已完成
2 期
Integrated Treatment for Cocaine and Mood Disorders - 1Cocaine DependenceDepressive Disorder, MajorNCT00227812National Institute on Drug Abuse (NIDA)140
已完成
3 期
The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.OsteoarthritisNCT00315848Purdue Pharma LP225